Sugi Predict

Sugi Predict / Compounds / SCHEMBL2469719

SCHEMBL2469719

SCHEMBL2469719

COCCc1c(C(=O)O)c(C)c2cc(Br)ccc2c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 3/20 0.39
▸ LDHB P07195 3/20 0.39
▸ RXFP1 Q9HBX9 4/20 0.38
▸ PRNP P04156 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ AURKA O14965 2/20 0.38
▸ AURKB Q96GD4 2/20 0.38
▸ KDR P35968 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ EGLN1 Q9GZT9 2/20 0.37
▸ DHODH Q02127 3/20 0.36
▸ PPARG P37231 2/20 0.36
▸ NR2E3 Q9Y5X4 2/20 0.36
▸ NCOR2 Q9Y618 2/20 0.36
▸ PTGER4 P35408 1/20 0.36
▸ PLA2G4A P47712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470719 0.82 LDHA (0.36) LDHALDHBTP53PPARGHCAR2
SCHEMBL27859472 0.73 SMN1; SMN2 (0.39) RXFP1PRNPKMT2AMEN1TP53
SCHEMBL18481324 0.73 ALDH1A1 (0.50) LDHALDHBRXFP1PRNPKMT2A
SCHEMBL2469717 0.68 TSHR (0.47) KMT2AMEN1TP53SMN1; SMN2ALDH1A1
SCHEMBL15100967 0.65 KDM4E (0.45) KMT2AMEN1SMN1; SMN2ALDH1A1PTGER4
SCHEMBL18481323 0.64 ALDH1A1 (0.50) KMT2AMEN1SMN1; SMN2ALDH1A1HTT
SCHEMBL10541146 0.64 ALDH1A1 (0.45) RXFP1PRNPKMT2AMEN1TP53
SCHEMBL28137800 0.64 RXFP1 (0.49) RXFP1PRNPKMT2AMEN1SMN1; SMN2
SCHEMBL2466414 0.64 RXFP1 (0.46) RXFP1KMT2AMEN1ALDH1A1HTT
SCHEMBL6824515 0.63 RXFP1 (0.41) RXFP1PRNPKMT2AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105199708-B Photochromic compounds 光学转变公司 2020-10-27 — — CN disclosed
EP-2370420-B9 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL INC (US) 2019-11-13 — — EP disclosed
EP-2370420-B1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL INC (US) 2019-05-22 — — EP disclosed
US-20180291009-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 — — US disclosed
US-20180291008-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 — — US disclosed
US-20180291007-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2018-10-11 — — US disclosed
US-10005763-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2018-06-26 — — US disclosed
US-10000472-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2018-06-19 — — US disclosed
US-20160332995-A1 Photochromic Comounds TRANSITIONS OPTICAL, INC. 2016-11-17 — — US disclosed
US-20160333262-A1 Photochromic Compounds TRANSITIONS OPTICAL, INC. 2016-11-17 — — US disclosed
US-9405041-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2016-08-02 — — US disclosed
US-20140154514-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2014-06-05 — — US disclosed
US-8705160-B2 Photochromic compounds TRANSITIONS OPTICAL, INC. (US) 2014-04-22 — — US disclosed
US-20120200907-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2012-08-09 — — US disclosed
US-8211338-B2 Photochromic compounds TRANSITIONS OPTICAL, INC (US) 2012-07-03 — — US disclosed
EP-2370420-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2011-10-05 — — EP disclosed
WO-2010065393-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2010-06-10 — — WO disclosed
US-20090309076-A1 PHOTOCHROMIC COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2009-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180291007-A1 Photochromic Compounds CCR4, CCR8, CBR3 LDHA 4754/4885LDHB 4774/4885RXFP1 1321/4885
US-20160332995-A1 Photochromic Comounds CCR4, CCR3, CCR8 LDHA 4793/4885LDHB 4808/4885RXFP1 942/4885
US-10005763-B2 Photochromic compounds CCR4, CCR8, CBR3 LDHA 4749/4885LDHB 4771/4885RXFP1 1313/4885
US-20180291008-A1 Photochromic Compounds CCR4, CBR3, CCR8 LDHA 4734/4885LDHB 4758/4885RXFP1 1233/4885
US-20160333262-A1 Photochromic Compounds CCR4, CCR8, CBR3 LDHA 4749/4885LDHB 4771/4885RXFP1 1313/4885
US-20180291009-A1 Photochromic Compounds CCR4, CCR8, CBR3 LDHA 4755/4885LDHB 4773/4885RXFP1 1345/4885
US-10000472-B2 Photochromic compounds CCR4, CCR8, CBR3 LDHA 4749/4885LDHB 4771/4885RXFP1 1313/4885
US-20120200907-A1 PHOTOCHROMIC COMPOUNDS CCR4, CCR8, CBR3 LDHA 4749/4885LDHB 4774/4885RXFP1 1319/4885
US-20090309076-A1 PHOTOCHROMIC COMPOUNDS CCR4, CCR8, CBR3 LDHA 4749/4885LDHB 4771/4885RXFP1 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.